RAPA-501-Allo

RAPA-501-Allo Uses, Dosage, Side Effects, Food Interaction and all others data.

RAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed ex vivo in a process that involves de-differentiation and re-differentiation.

Trade Name RAPA-501-Allo
Generic RAPA-501-Allo
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
RAPA-501-Allo
RAPA-501-Allo

How RAPA-501-Allo works

The hybrid TREG and Th2 phenotype of these cells inhibits the inflammatory pathways of COVID-19 through modulation of cytokines and chemokines and cross-regulation of Th1 and Th17 populations. This therapy also has been seen to mediate protection on lung alveolar tissue. The immunomodulation that occurs is in a T-cell receptor independent manner. Currently, RAPA-501-ALLO is being investigated against COVID-19.

Innovators Monograph

You find simplified version here RAPA-501-Allo


*** Taking medicines without doctor's advice can cause long-term problems.
Share